Rezolute, Inc.: Opaleye Management Inc. amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Opaleye Management Inc. filed an amended Schedule 13G with the SEC (accession 0001493152-26-051706) updating its beneficial ownership stake in Rezolute, Inc. The filing signals a change in the institutional investor's position in the clinical-stage biopharmaceutical company. The amendment matters because 13G updates can reveal shifts in major holders' conviction, though the headline did not disclose specific share counts or percentage changes. Investors will watch for the full filing details to gauge whether Opaleye increased, trimmed or maintained its stake.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Opaleye Management Inc., Rezolute, Inc.